New Deputy Minister of Health in Israel fully committed to cannabis legalization

Israeli cannabis patients and industry practitioners were pleased to hear of the appointment of MK Yoav Kish, a legalization supporter fully committed to the development of the cannabis industry, in the post of Deputy Minister of Health of Israel. This week, he was given responsibility for the field and promised to address the problems that the new reform brought.

Kish’s remarks in a conversation with cannabis patients, doctors and experts in the cannabis research field show that after a decade of ignoring and stiffening from the Litzman and German health ministries, for the first time, at least, patients will have a listening ear for policymakers.

If you want to know more about cannabis, how Israeli government officials support the cannabis industry, and to find out the latest hemp news, download the Hemp.im mobile application.

Yoav Kish fully committed to the development of the cannabis industry in Israel

“I promise to rectify the situation,” announced the deputy minister Yoav Kish, who has recently also expressed support for regulating a completely legal cannabis market for recreational purposes (“legalization”). He further noted that he was aware of the tough criticism of the industry reform that led to shortages and price rises.

Cannabis is a necessary cure for thousands of patients in the country who are looking for alternative treatments, he wrote. “The Ministry of Health has reformed the issue with a view to regulating the medical cannabis market. The reform includes many changes that created difficulties for cannabis patients, drew severe criticism to the industry and even reached the High Court.

“I intend to study and deepen the topic in order to formulate conclusions and understandings about how action should be taken and what needs to be changed to ease the suffering of many patients,” he concluded. In response, cannabis patients across the country praised him and expressed hope for a change soon.

The arrival of Deputy Minister Kish to the head of the Ministry of Health is of course not the only news for medical cannabis patients. The minister, Edelstein, also supports cannabis-based products as a significant relief for patients with specific diseases and even treated his wife with medical cannabis after she became ill.

This support from senior Health Ministry officials give more hope to cannabis patients, who are looking for more legal cannabis options in order to treat their illness. It also offers new opportunities to those in the cannabis industry who are waiting for the required regulatory relief to dive into the cannabis market. A policy that will allow cannabis export abroad, and, first and foremost, like patients, a listening ear to their claims.

Will these appointments also lead to personal changes in the Medical Cannabis Unit (YCR)? Recent rumors that the job of Chief Executive Yuval Landshaft is swinging has not been verified and he is still “sitting” on a special clerical standard, a “post office,” without expiry.

At the moment, cannabis patients are waiting for an update that the Ministry of Health will present to the High Court as part of the petition seeking to freeze the reform and significantly ease the new procedures in the cannabis industry. Next week the response will be delivered and a discussion will be held or a final decision will be made.

__

(Featured Image by GAD-BM via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in קנאביס, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.